Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,365,180

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 6,365,180 protect, and when does it expire?

Patent 6,365,180 protects ZIPSOR and is included in one NDA.

This patent has twenty-six patent family members in nineteen countries.

Summary for Patent: 6,365,180
Title: Oral liquid compositions
Abstract:The present invention relates to novel, liquid and semi-solid pharmaceutical compositions which can be administered in liquid form or can be used for preparing capsules containing such pharmaceutical compositions. Also provided are methods of using and processes for preparing the pharmaceutical compositions of the present invention.
Inventor(s): Meyer; Glenn A. (Wilmington, NC), Trespidi; Laura A. (89073 Ulm, DE), Wilson; Edward S. (Wilmington, NC), Clark; Christy M. (Southport, NC), Desai; Ashok J. (Wilmington, NC), Sancilio; Frederick D. (Wilmington, NC)
Application Number:09/354,982
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,365,180
Patent Claim Types:
see list of patent claims
Composition; Use; Dosage form; Process; Formulation;

Drugs Protected by US Patent 6,365,180

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Assertio ZIPSOR diclofenac potassium CAPSULE;ORAL 022202-001 Jun 16, 2009 AB RX Yes Yes   Start Trial   Start Trial Y NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,365,180

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 429210   Start Trial
Australia 2117399   Start Trial
Australia 6216800   Start Trial
Australia 770772   Start Trial
Brazil 0012488   Start Trial
Canada 2318128   Start Trial
Canada 2376180   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.